Prevalence of Arterial Hypertension in the Population of the Amur Region According to the “Measure Your Blood Pressure” Campaign
https://doi.org/10.22448/AMJ.2026.1.7-13
EDN: NNFJQK
Abstract
Objective. To study the awareness of the population of the Amur region about arterial hypertension (AH) and to assess the prevalence of the disease, the level of control and treatment adherence within the framework of the annual screening campaign “Measure Your Blood Pressure.”
Materials and methods. During the period from 2023 to 2025, a screening of 324 residents of the Amur region was conducted. Blood pressure (BP) measurements were performed using automatic and mechanical tonometers. Participants completed a questionnaire that included questions about the presence of hypertension, cardiovascular diseases, diabetes mellitus, smoking, history of COVID-19, and use of antihypertensive drugs. Hypertension was diagnosed at systolic BP ≥140 mmHg, diastolic BP ≥90 mmHg, or receiving therapy. Statistical analysis was performed using Statistica 10.0 software.
Results. Elevated BP was detected in an average of 49.5% of participants, with a predominance among women and middle-aged/elderly individuals. In 2025, compared to 2024, a 1.5-fold increase in hypertension among men was revealed. A significant prevalence of risk factors was noted: smoking (60.4%), overweight and obesity (38.6%), history of COVID-19 (90.8%). The proportion of individuals with newly diagnosed hypertension increased from 15.3% in 2023 to 28.5% in 2025, mainly among young men. Only 45.3% of patients with hypertension received antihypertensive therapy, while the target BP level was achieved in only 41.1%, indicating low adherence and insufficient treatment effectiveness.
Conclusion. The screening confirmed a high prevalence of hypertension among the population of the Amur region with a low level of awareness, especially among men. Insufficient treatment adherence and low effectiveness of antihypertensive therapy were revealed. It is necessary to strengthen educational work on hypertension risk factors, the importance of regular BP monitoring, and preventive measures.
About the Authors
I. G. MenshikovRussian Federation
Iraida G. Menshikova
Blagoveshchensk
A. D. Yakimov
Russian Federation
Alexander D. Yakimov
Blagoveshchensk
E. V. Magalyas
Russian Federation
Elena V. Magalyas
Blagoveshchensk
I. V. Sklyar
Russian Federation
Irina V. Sklyar
Blagoveshchensk
N. V. Loskutova
Russian Federation
Natalya V. Loskutova
Blagoveshchensk
Yu. V. Vakhnenko
Russian Federation
Yulia V. Vakhnenko
Blagoveshchensk
References
1. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024; 29 (9): 6117. DOI: https://doi.org/10.15829/1560-4071-2024-6117 (In Russ.)
2. Chazova I.E., Chikhladze N.M., Blinova N.V., et al. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024). Systemic Hypertension. 2024; 21 (4): 5–110. DOI: https://doi.org/10.38109/2075-082X-2024-4-5-109 (In Russ.)
3. Balanova Yu.A., Drapkina O.M., Kutsenko V.A., et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023; 22 (8S): 105–120. DOI: https://doi.org/10.15829/1728-8800-2023-3785 (In Russ.)
4. Chazova I.E., Solntseva T.D., Sivakova O.A., et al. Russian Medical Society for Arterial Hypertension expert consensus. Arterial hypertension and adherence to antihypertensive therapy. Systemic Hypertension. 2024; 21 (2): 7–17. DOI: https://doi.org/10.38109/2075-082X-2024-2-5-15 (In Russ.)
5. Schlaich M.P., Carrington M. May measurement month 2017-a concerted global effort to raise awareness of elevated blood pressure. Journal of Human Hypertension. 2018; 32 (5): 319–320. DOI: https://doi.org/10.1038/s41371-017-0006-1
6. Beaney T., Schutte A.E., Tomaszewski M., et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Global Health. 2018; 6 (7): e736–e743 DOI: https://doi.org/10.1016/S2214-109X(18)30259-6
7. Rotar O.P., Moguchaya E.V., Boyarinova M.A., et al. Treatment of hypertensive patients in Russian real-world practice based on the data from 2025 blood pressure measurement campaign. Russian Journal of Cardiology. 2025; 30 (9): 6490. DOI: https://doi.org/10.15829/1560-4071-2025-6490 (In Russ.)
8. Rotar O.P., Tolkunova K.M., Mevsha O.V., et al. Screening blood pressure measurement in the Russian population (the results of the МММ17 activity). Arterial Hypertension. 2018; 24 (4): 448–458. DOI: https://doi.org/10.18705/1607-419X-2018-24-4-448-458 (In Russ.)
9. McEvoy J.W., McCarthy K.P., Bruno R.M., et al.; ESC Scientific Document Group. ESC 2024 recommendations for the treatment of high blood pressure and hypertension. European Heart Journal. 2024; 45 (38): 3912–4018. DOI: https://doi.org/10.1093/eurheartj/ehae178
10. Drapkina O.M., Boytsov S.A., Atyunina I.V., et al. Outpatient follow-up of hypertensive patients by a primary care physician. Guidelines. Primary Health Care (Russian Federation). 2025; 2 (2): 206–236. DOI: https://doi.org/10.15829/3034-4123-2025-55 (In Russ.)
Review
For citations:
Menshikov I.G., Yakimov A.D., Magalyas E.V., Sklyar I.V., Loskutova N.V., Vakhnenko Yu.V. Prevalence of Arterial Hypertension in the Population of the Amur Region According to the “Measure Your Blood Pressure” Campaign. Amur Medical Journal. 2026;14(1):7-13. (In Russ.) https://doi.org/10.22448/AMJ.2026.1.7-13. EDN: NNFJQK
JATS XML











